This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Milk Types and Fish Oil in 9- to 12-Month-Old Infants

This study has been completed.
Anjo A/S
Information provided by:
University of Copenhagen Identifier:
First received: September 20, 2006
Last updated: August 13, 2008
Last verified: August 2008
The objective of this intervention study is to examine the effect of whole cow's milk versus infant formula as primary milk sources with or without supplements of n-3 LCPUFA for growth, nutritional status, development, risk factors for later diseases and the impact on the intestinal microbiota and inflammation in 9 - 12 months old infants.

Condition Intervention
Obesity Metabolic Syndrome Growth Blood Pressure Cardiovascular Disease Behavioral: Cow's milk with fish oil Behavioral: Cow's milk without fish oil Behavioral: Formula with fish oil Behavioral: Formula without fish oil

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: The Importance of Complementary Feeding on Growth, Nutritional Status and Markers for Disease. An Intervention Study With Milk Types and LC-PUFA Supplements in 9- to 12-Month-Old Infants

Resource links provided by NLM:

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • Growth
  • Body composition (weight, length, knee-heel-length, waist, head, and arm circumference, skin fold measurements).
  • IGF-I
  • IGFBP-3
  • Insulin - glucose metabolism (HOMA index).
  • Urea Nitrogen
  • Albumin
  • C-peptide
  • Amino Acids
  • Erythrocyte fatty acid composition
  • Blood pressure
  • Lipid Profile
  • Heart Rate Variability (HRV)
  • In vitro cytokine production from stimulated full blood (IL-10, IFN-gamma, TNF-alpha)
  • Plasma IgE, IL-2R, and CRP

Secondary Outcome Measures:
  • Plasma concentrations of cholesterol and triglycerides
  • Allergy status
  • Cognitive test ("The infant means-end problem solving test")
  • Iron status (hemoglobin, ferritin and transferrin receptors)
  • Feces samples: Calprotectin, IgA and composition of the intestinal microbiota

Estimated Enrollment: 100
Study Start Date: May 2003
Estimated Study Completion Date: March 2004

Ages Eligible for Study:   8 Months to 12 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Singleton infants
  • Born >= 37 wk of gestation
  • Birth weight > 2500g
  • >= 5th percentile for gestational age
  • A 5-min Apgar score >= 7
  • Daily consumption of cow's milk or formula

Exclusion Criteria:

  • No major complications at birth or in fetal life
  • No chronic diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00379171

Sponsors and Collaborators
University of Copenhagen
Anjo A/S
Study Chair: Kim F Michaelsen, Dr Med Sci Institute of Human Nutrition, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark
  More Information

Additional Information:
Publications: Identifier: NCT00379171     History of Changes
Other Study ID Numbers: KF 02-014/03
Study First Received: September 20, 2006
Last Updated: August 13, 2008

Keywords provided by University of Copenhagen:
Complementary feeding
Breast feeding
Cow's milk
Fish oil
Lipid profile
Intestinal inflammation
Intestinal microbiota

Additional relevant MeSH terms:
Cardiovascular Diseases
Metabolic Syndrome X
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases processed this record on August 23, 2017